IBDEI0SK ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,12855,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12855,1,3,0)
;;=3^Microcystoid Degeneration or Retina,OD
;;^UTILITY(U,$J,358.3,12855,1,4,0)
;;=4^H35.421
;;^UTILITY(U,$J,358.3,12855,2)
;;=^5005675
;;^UTILITY(U,$J,358.3,12856,0)
;;=H35.422^^51^622^20
;;^UTILITY(U,$J,358.3,12856,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12856,1,3,0)
;;=3^Microcystoid Degeneration or Retina,OS
;;^UTILITY(U,$J,358.3,12856,1,4,0)
;;=4^H35.422
;;^UTILITY(U,$J,358.3,12856,2)
;;=^5005676
;;^UTILITY(U,$J,358.3,12857,0)
;;=H35.423^^51^622^21
;;^UTILITY(U,$J,358.3,12857,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12857,1,3,0)
;;=3^Microcystoid Degeneration or Retina,Bilateral
;;^UTILITY(U,$J,358.3,12857,1,4,0)
;;=4^H35.423
;;^UTILITY(U,$J,358.3,12857,2)
;;=^5005677
;;^UTILITY(U,$J,358.3,12858,0)
;;=H35.451^^51^622^23
;;^UTILITY(U,$J,358.3,12858,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12858,1,3,0)
;;=3^Secondary Pigmentary Degeneration,OD
;;^UTILITY(U,$J,358.3,12858,1,4,0)
;;=4^H35.451
;;^UTILITY(U,$J,358.3,12858,2)
;;=^5005687
;;^UTILITY(U,$J,358.3,12859,0)
;;=H35.452^^51^622^24
;;^UTILITY(U,$J,358.3,12859,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12859,1,3,0)
;;=3^Secondary Pigmentary Degeneration,OS
;;^UTILITY(U,$J,358.3,12859,1,4,0)
;;=4^H35.452
;;^UTILITY(U,$J,358.3,12859,2)
;;=^5005688
;;^UTILITY(U,$J,358.3,12860,0)
;;=H35.453^^51^622^25
;;^UTILITY(U,$J,358.3,12860,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12860,1,3,0)
;;=3^Secondary Pigmentary Degeneration,Bilateral
;;^UTILITY(U,$J,358.3,12860,1,4,0)
;;=4^H35.453
;;^UTILITY(U,$J,358.3,12860,2)
;;=^5005689
;;^UTILITY(U,$J,358.3,12861,0)
;;=H35.381^^51^622^16
;;^UTILITY(U,$J,358.3,12861,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12861,1,3,0)
;;=3^Toxic Maculopathy,OD
;;^UTILITY(U,$J,358.3,12861,1,4,0)
;;=4^H35.381
;;^UTILITY(U,$J,358.3,12861,2)
;;=^5005666
;;^UTILITY(U,$J,358.3,12862,0)
;;=H35.382^^51^622^17
;;^UTILITY(U,$J,358.3,12862,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12862,1,3,0)
;;=3^Toxic Maculopathy,OS
;;^UTILITY(U,$J,358.3,12862,1,4,0)
;;=4^H35.382
;;^UTILITY(U,$J,358.3,12862,2)
;;=^5005667
;;^UTILITY(U,$J,358.3,12863,0)
;;=H35.383^^51^622^18
;;^UTILITY(U,$J,358.3,12863,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12863,1,3,0)
;;=3^Toxic Maculopathy,Bilateral
;;^UTILITY(U,$J,358.3,12863,1,4,0)
;;=4^H35.383
;;^UTILITY(U,$J,358.3,12863,2)
;;=^5005668
;;^UTILITY(U,$J,358.3,12864,0)
;;=H35.343^^51^622^12
;;^UTILITY(U,$J,358.3,12864,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12864,1,3,0)
;;=3^Macular Cyst,Hole,or Pseudohole,Bilateral
;;^UTILITY(U,$J,358.3,12864,1,4,0)
;;=4^H35.343
;;^UTILITY(U,$J,358.3,12864,2)
;;=^5005652
;;^UTILITY(U,$J,358.3,12865,0)
;;=H35.031^^51^623^1
;;^UTILITY(U,$J,358.3,12865,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12865,1,3,0)
;;=3^HTN Retinopathy,OD
;;^UTILITY(U,$J,358.3,12865,1,4,0)
;;=4^H35.031
;;^UTILITY(U,$J,358.3,12865,2)
;;=^5005590
;;^UTILITY(U,$J,358.3,12866,0)
;;=H35.032^^51^623^2
;;^UTILITY(U,$J,358.3,12866,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12866,1,3,0)
;;=3^HTN Retinopathy,OS
;;^UTILITY(U,$J,358.3,12866,1,4,0)
;;=4^H35.032
;;^UTILITY(U,$J,358.3,12866,2)
;;=^5005591
;;^UTILITY(U,$J,358.3,12867,0)
;;=H35.033^^51^623^3
;;^UTILITY(U,$J,358.3,12867,1,0)
;;=^358.31IA^4^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0SK 3747 printed Sep 23, 2025@19:30:56 Page 2
IBDEI0SK ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,12855,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,12855,1,3,0)
+4 ;;=3^Microcystoid Degeneration or Retina,OD
+5 ;;^UTILITY(U,$J,358.3,12855,1,4,0)
+6 ;;=4^H35.421
+7 ;;^UTILITY(U,$J,358.3,12855,2)
+8 ;;=^5005675
+9 ;;^UTILITY(U,$J,358.3,12856,0)
+10 ;;=H35.422^^51^622^20
+11 ;;^UTILITY(U,$J,358.3,12856,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,12856,1,3,0)
+14 ;;=3^Microcystoid Degeneration or Retina,OS
+15 ;;^UTILITY(U,$J,358.3,12856,1,4,0)
+16 ;;=4^H35.422
+17 ;;^UTILITY(U,$J,358.3,12856,2)
+18 ;;=^5005676
+19 ;;^UTILITY(U,$J,358.3,12857,0)
+20 ;;=H35.423^^51^622^21
+21 ;;^UTILITY(U,$J,358.3,12857,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,12857,1,3,0)
+24 ;;=3^Microcystoid Degeneration or Retina,Bilateral
+25 ;;^UTILITY(U,$J,358.3,12857,1,4,0)
+26 ;;=4^H35.423
+27 ;;^UTILITY(U,$J,358.3,12857,2)
+28 ;;=^5005677
+29 ;;^UTILITY(U,$J,358.3,12858,0)
+30 ;;=H35.451^^51^622^23
+31 ;;^UTILITY(U,$J,358.3,12858,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,12858,1,3,0)
+34 ;;=3^Secondary Pigmentary Degeneration,OD
+35 ;;^UTILITY(U,$J,358.3,12858,1,4,0)
+36 ;;=4^H35.451
+37 ;;^UTILITY(U,$J,358.3,12858,2)
+38 ;;=^5005687
+39 ;;^UTILITY(U,$J,358.3,12859,0)
+40 ;;=H35.452^^51^622^24
+41 ;;^UTILITY(U,$J,358.3,12859,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,12859,1,3,0)
+44 ;;=3^Secondary Pigmentary Degeneration,OS
+45 ;;^UTILITY(U,$J,358.3,12859,1,4,0)
+46 ;;=4^H35.452
+47 ;;^UTILITY(U,$J,358.3,12859,2)
+48 ;;=^5005688
+49 ;;^UTILITY(U,$J,358.3,12860,0)
+50 ;;=H35.453^^51^622^25
+51 ;;^UTILITY(U,$J,358.3,12860,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,12860,1,3,0)
+54 ;;=3^Secondary Pigmentary Degeneration,Bilateral
+55 ;;^UTILITY(U,$J,358.3,12860,1,4,0)
+56 ;;=4^H35.453
+57 ;;^UTILITY(U,$J,358.3,12860,2)
+58 ;;=^5005689
+59 ;;^UTILITY(U,$J,358.3,12861,0)
+60 ;;=H35.381^^51^622^16
+61 ;;^UTILITY(U,$J,358.3,12861,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,12861,1,3,0)
+64 ;;=3^Toxic Maculopathy,OD
+65 ;;^UTILITY(U,$J,358.3,12861,1,4,0)
+66 ;;=4^H35.381
+67 ;;^UTILITY(U,$J,358.3,12861,2)
+68 ;;=^5005666
+69 ;;^UTILITY(U,$J,358.3,12862,0)
+70 ;;=H35.382^^51^622^17
+71 ;;^UTILITY(U,$J,358.3,12862,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,12862,1,3,0)
+74 ;;=3^Toxic Maculopathy,OS
+75 ;;^UTILITY(U,$J,358.3,12862,1,4,0)
+76 ;;=4^H35.382
+77 ;;^UTILITY(U,$J,358.3,12862,2)
+78 ;;=^5005667
+79 ;;^UTILITY(U,$J,358.3,12863,0)
+80 ;;=H35.383^^51^622^18
+81 ;;^UTILITY(U,$J,358.3,12863,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,12863,1,3,0)
+84 ;;=3^Toxic Maculopathy,Bilateral
+85 ;;^UTILITY(U,$J,358.3,12863,1,4,0)
+86 ;;=4^H35.383
+87 ;;^UTILITY(U,$J,358.3,12863,2)
+88 ;;=^5005668
+89 ;;^UTILITY(U,$J,358.3,12864,0)
+90 ;;=H35.343^^51^622^12
+91 ;;^UTILITY(U,$J,358.3,12864,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,12864,1,3,0)
+94 ;;=3^Macular Cyst,Hole,or Pseudohole,Bilateral
+95 ;;^UTILITY(U,$J,358.3,12864,1,4,0)
+96 ;;=4^H35.343
+97 ;;^UTILITY(U,$J,358.3,12864,2)
+98 ;;=^5005652
+99 ;;^UTILITY(U,$J,358.3,12865,0)
+100 ;;=H35.031^^51^623^1
+101 ;;^UTILITY(U,$J,358.3,12865,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,12865,1,3,0)
+104 ;;=3^HTN Retinopathy,OD
+105 ;;^UTILITY(U,$J,358.3,12865,1,4,0)
+106 ;;=4^H35.031
+107 ;;^UTILITY(U,$J,358.3,12865,2)
+108 ;;=^5005590
+109 ;;^UTILITY(U,$J,358.3,12866,0)
+110 ;;=H35.032^^51^623^2
+111 ;;^UTILITY(U,$J,358.3,12866,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,12866,1,3,0)
+114 ;;=3^HTN Retinopathy,OS
+115 ;;^UTILITY(U,$J,358.3,12866,1,4,0)
+116 ;;=4^H35.032
+117 ;;^UTILITY(U,$J,358.3,12866,2)
+118 ;;=^5005591
+119 ;;^UTILITY(U,$J,358.3,12867,0)
+120 ;;=H35.033^^51^623^3
+121 ;;^UTILITY(U,$J,358.3,12867,1,0)
+122 ;;=^358.31IA^4^2
